AC
DWTX

Armistice Capital’s Dogwood Therapeutics DWTX Stock Holding History

Armistice Capital’s Portfolio DWTX Stock Details DWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.92M Buy
+3,280,000
New +$9.65M 0.12% 108

Other funds holding DWTX

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital's DWTX Position: Q1 2026 in Review

Armistice Capital opened a new position in Dogwood Therapeutics (DWTX) in Q1 2026: 3,280,000 shares worth $6.92M. The stake represents 0.12% of the portfolio and ranks #108 among its holdings.

13 funds tracked by Wall St. Rank hold DWTX as of Q1 2026.

  • Armistice Capital held 3,280,000 shares of Dogwood Therapeutics worth $6.92M as of Q1 2026.
  • Dogwood Therapeutics was a new Armistice Capital position in Q1 2026.
  • Dogwood Therapeutics made up 0.12% of Armistice Capital's portfolio in Q1 2026, its #108 holding.
  • 13 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q1 2026.

Based on Armistice Capital's 13F filing for Q1 2026, filed 15 May 2026.